Safety and Efficacy of Antiadhesive Barrier GUARDIX-FL for Women After Laparoscopic Cystectomy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
* Indication: Benign tumors of ovary(mature teratoma, mucinous cystadenoma, serous cystadenoma) * Intervention: Device ( Test group : Guardix-FL, Control group : Interceed) * Primary Outcome Measure : Anti-adhesion Rate * Assessment : Operative Day(Visit 2), Post-Operative Day+7days(Vist 3), Post-Operative Day+4weeks(Visit4), Post-Operative Day+5weeks(Visit 5)
Epistemonikos ID: 24bdb2362533f90e9d52f0bc0aa08bd70217c560
First added on: May 11, 2024